If you doubled your marketing spend tomorrow, would you double your sales?

Most cannabis marketing does not fail because teams spend too little. It fails because marketing is asked to create success while known problems remain unfixed. That is why marketing is often the first thing cut when results stall.

What has changed is that modern tracking makes attribution clearer and easier than ever. Attribution means understanding which actions actually drive revenue, not just traffic or activity.

This week we sit down with John Shute to discuss:

• Why marketing gets blamed for upstream failures
• How attribution reveals what is actually working
• Where most teams are missing 

Chapters

00:00 Navigating Budget Cuts in Cannabis Marketing

02:59 The Importance of Trackable Marketing Strategies

06:05 Understanding Consumer Behavior and Retention

08:53 Leveraging Data for Brand Growth

11:59 The Role of Email Marketing in Cannabis Brands

15:10 Product Quality and Consumer Safety

18:01 Narrowing Focus for Brand Success

23:26 Smart Growth Strategies in Cannabis Marketing

26:24 The Importance of Data-Driven Decisions

27:21 Closing the Gap: SEO and Market Positioning

30:27 Maximizing Marketing ROI

33:03 Understanding Marketing Attribution

36:14 Navigating Challenges in Client Relationships

39:19 The Complexity of Marketing in Cannabis

45:04 Community Engagement and Social Responsibility

Summary

In this conversation, John Shute discusses the challenges and strategies of marketing within the cannabis industry, particularly in the context of budget cuts. He emphasizes the importance of trackable marketing efforts, such as email marketing, and the need for brands to focus on consumer retention and data analytics. John also highlights the significance of building a strong brand identity and ensuring product quality and consumer safety. The discussion touches on the evolving landscape of cannabis marketing, the necessity for comprehensive audits, and the value of community engagement initiatives.

Guest Links

• https://x.com/johnshute_
• https://www.linkedin.com/in/john-shute-pufcreativ/
• https://www.instagram.com/pufcreativ/
• https://www.youtube.com/channel/UCY2pdmT1-QHKux8728PRy2A
• https://www.linkedin.com/company/pufcreativ
• https://pufcreativ.com/

Our Links

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared  global podcast

The Dime is a top 10 Cannabis Podcast 

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Exceptional extraction has long been treated as an art.
What separates the best teams is not creativity.
It is the ability to repeat quality, consistently.

And it is not SOP alone.

It is judgment applied consistently under real constraints. Constraints that define what is technically possible, operationally realistic, and economically viable.

Those constraints tart with understanding your system and tracking the right operational parameters at a level of detail most teams never reach.

That depth of understanding is what allows teams to produce a consistent, high-quality end product instead of relying on feel or memory.

This week we sit down with Brian Adams to discuss

• How to balance SOPs with operator flexibility
• How to think clearly about your extraction system and its limits
• Whether rolling back adult use in Massachusetts is real or noise

Chapters

00:00 The Complexity of Extraction Processes

03:06 Adapting SOPs for Optimal Results

06:04 Understanding Cost Structures in Extraction

09:12 The Importance of Hardware in Product Quality

12:07 Navigating Consumer Expectations and Feedback

15:10 Quality Control and Brand Reputation

18:11 Expanding Product Categories and Maintaining Standards

21:07 Educating Consumers on Concentrate Differences

23:56 The Future of the Cannabis Industry in Massachusetts

30:32 The Current State of Cannabis in Massachusetts

34:27 The Threat of Opposition and Industry Response

39:55 Navigating Negative Perceptions and Future Outlook

41:14 The Importance of Industry Unity and Consumer Education

42:29 Engaging with Consumers and Building a Brand

Summary

In this conversation, Bryan Fields and Brian Adams delve into the complexities of extraction processes in the cannabis industry, emphasizing the importance of flexibility in Standard Operating Procedures (SOPs) to achieve optimal results. They discuss the significance of understanding cost structures, the role of hardware in product quality, and the challenges of maintaining brand reputation amidst consumer feedback. The conversation also touches on the need for consumer education regarding concentrate differences and the potential future of the cannabis industry in Massachusetts. In this conversation, Brian Adams discusses the current challenges facing the cannabis industry in Massachusetts, particularly in light of recent negative news and opposition movements. He emphasizes the need for industry unity to combat misinformation and protect the rights of consumers. The discussion also touches on the importance of educating consumers about cannabis production and the potential impact of regulatory changes on the industry.

Guest Links:

https://www.nimbuscannabisco.com/https://www.nimbuscannabisco.com/

Our Links

• https://www.nimbuscannabisco.com/
• https://www.instagram.com/nimbuscc/
• https://www.linkedin.com/company/nimbus-cannabis-co/
• https://www.linkedin.com/company/hudson-botanical-processing/
• https://www.linkedin.com/in/jb-adams/

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared  global podcast

The Dime is a top 10 Cannabis Podcast 

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Most cannabis automation fails for a simple reason.
It optimizes motion instead of understanding.

Automation executes. Robotics adapts.
That distinction matters in an industry where variability is unavoidable and capital is limited.

This episode breaks down why feedback loops matter more than machines, why fully automated facilities are still far off, and how teams should think about constraints before investing.

This week, we sit down with Nohtal Partansky to cover:

• Why automation breaks under variability
• Automation vs robotics, clearly defined
• How to avoid expensive missteps

Chapters

00:00 Understanding Automation in Cannabis Manufacturing

03:02 The Role of Robotics vs. Automation

05:45 Consultative Approach to Automation

08:54 Challenges in Cultivation Automation

11:59 Designing for Variability in Automation

15:01 Iterative Development and Customer Feedback

18:08 Identifying Design vs. Customer Issues

21:06 Adapting to Environmental Nuances

23:55 Conveying Value in Automation Solutions

27:09 Strategic Approaches to Automation in Supply Chain

30:10 Optimizing Pre-Roll Production Processes

33:44 Understanding Tolerance Levels in Manufacturing

36:39 Intellectual Property in the Cannabis Industry

42:26 Innovations in Cannabis Manufacturing

45:32 Challenges in Automation and Scaling

50:51 Improving Processes and Training in Cannabis Operations

Summary

In this conversation, Bryan Fields and Nohtal Partansky delve into the intricacies of automation and robotics within the cannabis manufacturing industry. They discuss the differences between fully automated and automated processes, the consultative approach to implementing automation, and the challenges faced in cultivation. The conversation highlights the importance of feedback loops in robotics, the iterative design process, and the need for a deep understanding of customer needs. They also touch on the significance of protecting intellectual property while fostering innovation in a rapidly evolving industry.

Guest Links

• https://www.instagram.com/sortingroboticsinc/
• https://www.youtube.com/@sortingrobotics
• https://www.linkedin.com/company/sortingrobotics/
• https://www.sortingrobotics.com/
• https://www.linkedin.com/in/nohtal/

Our Links

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared  global podcast

The Dime is a top 10 Cannabis Podcast 

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jaunty’s rise to the top of the New York cannabis market was not an overnight success.
It was built through discipline in a market uniquely designed

New York’s rollout remains unforgiving.
One store openings, supply and demand constraints, and continuous price compression forced every decision into the open.

This week we sit down with Nicolas Guarino, Co-Founder and CEO of Jaunty, to break down what it actually takes to survive and scale in one of the most interesting cannabis markets in the country.

This week we sit down with Nick to discuss:

Why consistency becomes the only real moat as prices fall

How New York’s rollout punished assumptions and rewarded preparedness

Capital discipline, supplier trust, and avoiding overspend death spirals

Chapters

00:00 Introduction to Jaunty and Nicolas Guarino

03:06 The Journey into the Cannabis Industry

06:07 Challenges and Lessons Learned in CBD

09:00 Transitioning to Recreational Cannabis

11:54 Building a Brand in a Competitive Market

15:07 Navigating Market Dynamics and Growth Challenges

18:07 The Importance of Support and Resilience

20:49 Understanding Market Economics and Consumer Behavior

23:55 Future Prospects for Cannabis in New York

31:48 The Economics of Cannabis Production

36:29 The Importance of Consistency in Branding

41:11 Navigating Challenges in Cannabis Operations

46:10 Strategic Planning for Future Growth

51:56 Inventory Management and Cost Control

56:02 Preparing for Market Consolidation

58:11 Final Thoughts and Future Directions

About: Nicolas Guarino is Co-Founder and CEO of Jaunty. As a GMP-certified 100% New York company working in cannabis extraction since 2017, Jaunty has been producing and distributing the finest solventless hash, live resin, and distillate cannabis products in its mission to close the gap between flower and oil. With state-of-the-art manufacturing facilities in Hoosick Falls, NY, Jaunty is one of New York's leading companies licensed for all adult-use cannabis supply chain activities outside of retail, including cultivation, processing, manufacturing, and distribution. They produce and distribute one of New York’s best-selling cannabis vape brands, available in all of the state’s licensed dispensaries, and their product portfolio also features gummies, concentrates, and disposable vapes.

Summary

In this episode, Bryan Fields interviews Nicolas Guarino, co-founder and CEO of Jaunty, discussing his journey in the cannabis industry, the challenges faced in the CBD market, and the transition to recreational cannabis. They explore the importance of brand consistency, financial strategies for growth, and the dynamics of the New York cannabis market. Nicholas shares insights on consumer education, market predictions, and the future vision for Jaunty emphasizing the need for adaptability and resilience in a fast-paced industry.

Guest Links

• https://jaunty.com/
• https://x.com/getjaunty
• https://www.linkedin.com/company/get-jaunty
• https://www.instagram.com/get_jaunty/
• https://www.linkedin.com/in/nicolas-guarino-43939b103/

Our Links:

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared  global podcast

The Dime is a top 10 Cannabis Podcast 

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Before CBD was discussed by a President in the Oval Office, it was a medical necessity.

The Charlotte Figi story is well documented — and powerful.
Not because it was emotional, but because it forced a serious medical conversation.

Stories like Charlotte’s change how physicians, regulators, and institutions think about where cannabinoid therapy belongs — not as a last resort, but as a legitimate option.

Charlotte’s Web was built around that reality. By recognizing that cannabis does have medicinal properties — and that patients should have access to a plant-based option when it can materially improve quality of life — the company focused on trust, standards, and medical credibility first.

This week, we sit down with Bill Morachnick to break down:

• Why CBD earned acceptance through medical trust, not consumer marketing
• How physician comfort, reimbursement pathways, and standards changed the conversation
• CBD in the Oval Office — and what that signals for the future of cannabis

Chapters

00:00 Introduction to Charlotte's Web and Bill Morachnick

03:00 The Inspiring Story of Charlotte Figi

05:51 The Executive Order and Its Implications

08:59 The Role of Education in CBD Acceptance

12:12 Challenges and Misconceptions in the Cannabis Industry

15:03 The Future of CBD and Medical Recommendations

18:06 The Impact of Federal Reimbursement on CBD

21:08 Defloria and the Future of Cannabis Research

24:01 Navigating Regulatory Changes and Industry Challenges

27:03 The Importance of Quality and Consistency in CBD Products

30:02 The Potential for Pharmaceutical Collaborations

33:04 Looking Ahead: The Future of CBD and Cannabis

36:13 Final Thoughts and Audience Engagement

Summary

In this episode, Bryan Fields interviews Bill Morachnick, CEO of Charlotte's Web, discussing the company's inspiring origins, the recent executive order regarding CBD, and the future of cannabis as a medicinal product. Bill shares the powerful story of Charlotte Figi, whose life was transformed by CBD, and emphasizes the importance of education in changing perceptions about cannabis. The conversation also touches on the challenges faced by the industry, the potential for pharmaceutical collaborations, and the impact of federal reimbursement on CBD products.

Guest Links:

• https://www.trycharlottesweb.com/
• https://www.charlottesweb.com/
• https://www.youtube.com/charlotteswebcbd
• https://www.instagram.com/charlotteswebcbd/
• https://www.linkedin.com/in/bill-morachnick-01318a6/
• https://www.linkedin.com/company/charlottesweb/

Our Links:

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared  global podcast

The Dime is a top 10 Cannabis Podcast 

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Everyone wants their product and brand to be known for consistency .
Almost no one is willing to do the difficult work that makes consistency possible.

This week we sit down with Ryan Crandall, Chief Commercial Officer at MariMed, to break down:

• Why most cannabis brands fail at scale — and how process control, not an artisanal mindset, determines who lasts
• How MariMed engineers consistency across states by centralizing inputs & testing aggressively,
• What it actually takes to make effects-based products consistent and repeatable

Chapters

00:00 Introduction to the Cannabis Industry and Edibles

03:05 The Evolution of Edibles: From Early Days to Now

06:01 Ensuring Consistency Across State Lines

09:09 Quality Control and Testing in Edibles

12:01 Consumer Education and Brand Trust

15:13 MariMed Brand Portfolio and Market Strategy

18:06 Role of R&D in Product Development

21:00 Future Trends and Innovations in Edibles

24:03 Building Relationships with Budtenders and Consumers

27:58 Exploring Cannabinoids: THCV and CBG Effects

30:06 Understanding Edible Experiences and Consumer Expectations

32:00 Responsible Product Development in the Cannabis Industry

33:52 Brand Strategy and Market Penetration in New States

35:51 Innovative Products: Vibations and Consumer Convenience

38:04 Navigating the Hemp Market and Brand Expansion

39:52 Consumer Behavior: Beverages vs. Edibles in Cannabis

44:02 The Importance of Team and Company Culture

Guest Links:

• https://www.marimedinc.com/
• https://www.linkedin.com/company/marimed-inc/about/
• https://www.linkedin.com/in/ryan-crandall-43133b12/
• https://x.com/MariMed_Inc

Summary

In this episode, Bryan Fields interviews Ryan Crandall, Chief Commercial Officer at MariMed, discussing the evolution of the cannabis industry, particularly focusing on edibles. They explore the importance of consistency in product quality across different states, the role of research and development in product innovation, and the significance of branding and consumer trust. Ryan shares insights into MariMeds diverse product portfolio and their approach to quality control and testing procedures. The conversation also touches on the future of hemp and cannabinoids, as well as the beverage market's impact on consumer behavior.

Our Links:

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared  global podcast

The Dime is a top 10 Cannabis Podcast 

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Schedule III isn’t the finish line.
It’s the starting gun.

The EO said a lot — but most operators aren’t ready for what it actually means.

This week we sit down with Zach Edge and Dr. Matthew Moore to break down:

• Why Schedule III is guidance, not rules — and why the real impact comes during rulemaking
• What GMP, CFR, and pharmaceutical-grade manufacturing will actually require from operators
• Which parts of the supply chain face the biggest disruption as cannabis moves forward

Chapters

00:00 Historic Changes in Cannabis Scheduling

03:13 The Impact of Hemp in the New Landscape

06:07 Strategic Shifts for Cannabis Operators

08:59 Navigating Regulatory Changes

11:58 The Role of Pharmacies in the New Market

15:04 Global Trade and Competition in Cannabis

17:53 Research Opportunities and Challenges

21:02 Veterans and the Future of CBD

24:02 The Supply Chain Dynamics

26:47 The Future of Hemp and CBD Products

29:56 Final Thoughts on the Cannabis Industry

Summary:

In this episode, Bryan Fields discusses the recent changes in cannabis scheduling with experts Zach Edge and Matthew Moore. They explore the implications of the new executive order, particularly regarding hemp and its potential impact on the industry. The conversation delves into the strategic shifts that cannabis operators need to consider, the role of compounding pharmacies, and the opportunities for research that arise from the new regulations. They also discuss the challenges in the supply chain and the potential market dynamics as the industry evolves.

Guest Links:

• https://www.linkedin.com/company/the-rho-advisory/
• https://www.linkedin.com/in/zach-edge/
• https://www.linkedin.com/in/mmoore09/

Our Links:

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared  global podcast

The Dime is a top 10 Cannabis Podcast 

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

SNDL is much bigger than most people realize — with global distribution, massive extraction capacity, and a diversified retail and manufacturing engine that touches nearly every part of the cannabis supply chain.

This week we sit down with Tyler Robson, President of SNDL, to break down:

• How SNDL became a global manufacturing and retail powerhouse
• Why extraction and derivatives are their true competitive edge
• How they operate across countries with completely different rules and product formats

Chapters

00:00 Introduction to Sundial and Tyler Robson

02:08 The Complexity of Extraction and Manufacturing

04:38 Merging Sundial and Valens: Challenges and Strategies

06:11 Sundial's Operations and Global Reach

07:39 Firefighting and Problem Solving in Leadership

09:52 Data-Driven Decision Making

12:44 Navigating Different Regulatory Environments

13:55 Core Competencies and Operational Efficiencies

15:46 Staying Focused in a Distracted Industry

16:18 Sundial's Market Position and Brand Partnerships

17:10 Strategic Focus on Texas and Florida

19:09 Resource Planning and Flexibility

20:42 Continuous Improvement in Manufacturing

22:34 Synergies Between Liquor and Cannabis

24:48 Future of Cannabis and Liquor Co-Mingling

26:30 Emerging International Markets

28:23 Potential Partnerships and Collaborations

30:08 The Size of the Global Cannabis Opportunity

31:31 Strategic Partnerships in the US

32:03 Conclusion and Key Takeaways

Summary

In this episode, Tyler Robson, president of Sundial, shares insights into his journey in the cannabis industry, the complexities of extraction and manufacturing, and the challenges of merging companies. He discusses Sundial's global operations, the importance of data-driven decision making, and the need for focus in a distracted industry. Tyler also highlights the potential for growth in emerging markets and the synergies between the cannabis and liquor industries, while emphasizing the significance of strategic partnerships.

Guest Links:

• https://sndl.com/homepage/default.aspx
• https://www.linkedin.com/in/tyler-robson-a77ba4155/
• https://www.linkedin.com/company/sndlinc/

[email protected]

Our Links:

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared  global podcast

The Dime is a top 10 Cannabis Podcast 

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Most operators think debt is dangerous. But what if the real problem is how we think about it?
The opposite is true: when used correctly, debt is the single biggest growth lever in cannabis. Every major industry scales on borrowed capital — cannabis is the only one still trying to do it alone.

This week we sit down with Adam Stettner to discuss:
• Why debt — used properly — compounds growth
• The difference between smart leverage and over-leverage
• How operators can fix cash-flow bottlenecks and scale predictably

Chapters

00:00 Introduction to Adam Stettner and FundCanna.

03:05 Adam's Journey into the Cannabis Industry

06:12 Understanding Underwriting in Cannabis Financing

09:05 The Importance of Client-Centric Financing

11:56 Navigating Complex Variables in Cannabis Lending

14:57 Building Infrastructure for Cannabis Financing

17:48 Segmenting the Cannabis Industry for Better Insights

20:55 The Unique Challenges of Cannabis Lending

24:12 The Role of Transparency in Client Relationships

28:23 Building Partnerships for Success

29:29 Funding Options for Operational Efficiency

32:29 Understanding Technology and Business Operations

37:54 Navigating Debt and Financial Strategies

42:10 Using Debt to Accelerate Growth

52:46 Exploring Funding Opportunities

Summary

In this episode, Bryan Fields and Kellen Finney welcome Adam Stettner, CEO of FundCanna, to discuss the complexities of cannabis financing. Adam shares his journey from the apparel industry to cannabis, emphasizing the importance of understanding the unique challenges of underwriting in this space. He highlights the need for a client-centric approach in lending, the significance of transparency, and the innovative strategies FunCounter employs to navigate the cannabis market. Adam also discusses the importance of knowledge sharing and the metrics that indicate success in cannabis financing. In this conversation, Adam Stettner discusses the importance of building partnerships in the cannabis industry, focusing on how funding can enhance operational efficiency and support business growth. He emphasizes the need for flexible financial solutions that allow businesses to thrive without being constrained by debt. Stettner also highlights the significance of understanding technology and its impact on business operations, advocating for a metrics-based approach to financial decisions. The discussion concludes with insights on leveraging debt as a tool for growth and the importance of fostering relationships in the industry.

Guest Links:

• https://fundcanna.com
• https://fundcanna.com/about/adam-stettner/
• https://www.linkedin.com/in/adamstettner
• https://www.linkedin.com/company/fundcanna/

About Adam Stettner:

Adam has 30 years of business, strategy and leadership experience in both Private and Public Companies. In 2021, Adam believed the timing and opportunity was right for him to bring his passion for business, innovative financing and entrepreneurial spirit to the Cannabis sector by creating funding products for all areas of this early stage, growth industry by founding FundCanna. FundCanna provides short term funding to all areas of the sector; cultivators, manufacturers, vendors, suppliers, distributors and retailers. In just its first year, FundCanna has underwritten roughly 3000 files and funded over 500 unique files bringing much needed liquidity and financing solutions to the legal Cannabis industry.

Our Links:

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared  global podcast

The Dime is a top 10 Cannabis Podcast 

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Everyone in cannabis talks about effects-based products — almost no one can deliver them consistently.

Repeatable experiences require precision and formulation discipline that looks a lot more like pharma than cannabis.

And here’s why: most operators don’t treat in-house analytics as essential. But that’s the mistake.

Process control isn’t optional — it’s the foundation for delivering the same experience every single time.

This week we sit down with Chris Emerson, Founder of LEVEL, to break down:
• How true effects-based products are actually built
• The analytics and standardization required for repeatability
• Why most teams can’t achieve consistency — and what it takes to fix it

Chapters

00:00 Introduction to Chris Emerson and Level

03:07 The Journey into Cannabis and Product Development

06:02 Challenges in Consistency and Formulation

08:48 Navigating the Market and Consumer Education

12:05 The Role of Cannabinoids and Future Innovations

14:56 Expanding Beyond California: Challenges and Strategies

27:32 The Importance of Consistency in Product Quality

29:51 Navigating the Medical vs Recreational Cannabis Landscape

33:03 Advanced Analytics in Cannabis Production

36:02 Innovations in Product Formulation and Consumer Experience

39:56 Strategic Approaches to Hemp and Cannabinoid Research

45:00 Exploring the Future of Cannabinoids and Consumer Education

Summary

In this conversation, Chris Emerson, founder of Level, shares his journey from academia to the cannabis industry, discussing the challenges and innovations in product development. He emphasizes the importance of effects-based formulations, consistency in product quality, and the need for consumer education in a rapidly evolving market. The discussion also touches on the future of cannabinoid products and the strategies for expanding into new markets while maintaining quality and consistency. In this conversation, Chris Emerson discusses the complexities of cannabis production, emphasizing the importance of consistency and advanced analytics in ensuring product quality. He explores the challenges faced by the medical cannabis market as it competes with recreational use, and shares insights on the evolving landscape of cannabinoid research, particularly focusing on the Varin class and acidic cannabinoids. The discussion also touches on strategic approaches to hemp and the significance of consumer education in navigating the cannabis industry.

Guest Links:

• https://www.linkedin.com/in/chris-emerson-ph-d-464b245a/
• https://www.instagram.com/level.experience
• https://www.linkedin.com/company/levelexperience/
• https://levelexperience.com/

Our Links:

Bryan Fields on Twitter

Kellan Finney on Twitter

The Dime on Twitter

Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

The Dime is a top 5% most shared  global podcast

The Dime is a top 10 Cannabis Podcast 

The Dime has a New Website. Shhhh its not finished.

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.